128 related articles for article (PubMed ID: 38423634)
1. Genotoxic and Cytotoxic Activity of Fisetin on Glioblastoma Cells.
Beltzig L; Christmann M; Dobreanu M; Kaina B
Anticancer Res; 2024 Mar; 44(3):901-910. PubMed ID: 38423634
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic and Senolytic Effects of Methadone in Combination with Temozolomide in Glioblastoma Cells.
Kaina B; Beltzig L; Piee-Staffa A; Haas B
Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977591
[TBL] [Abstract][Full Text] [Related]
3. Are There Thresholds in Glioblastoma Cell Death Responses Triggered by Temozolomide?
He Y; Kaina B
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925722
[TBL] [Abstract][Full Text] [Related]
4. Abrogation of Cellular Senescence Induced by Temozolomide in Glioblastoma Cells: Search for Senolytics.
Beltzig L; Christmann M; Kaina B
Cells; 2022 Aug; 11(16):. PubMed ID: 36010664
[TBL] [Abstract][Full Text] [Related]
5. Fisetin induces DNA double-strand break and interferes with the repair of radiation-induced damage to radiosensitize triple negative breast cancer cells.
Khozooei S; Lettau K; Barletta F; Jost T; Rebholz S; Veerappan S; Franz-Wachtel M; Macek B; Iliakis G; Distel LV; Zips D; Toulany M
J Exp Clin Cancer Res; 2022 Aug; 41(1):256. PubMed ID: 35989353
[TBL] [Abstract][Full Text] [Related]
6. Artesunate in glioblastoma therapy: Case reports and review of clinical studies.
Strik H; Efferth T; Kaina B
Phytomedicine; 2024 Jan; 123():155274. PubMed ID: 38142662
[TBL] [Abstract][Full Text] [Related]
7. Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL Inhibition.
Rahman M; Olson I; Mansour M; Carlstrom LP; Sutiwisesak R; Saber R; Rajani K; Warrington AE; Howard A; Schroeder M; Chen S; Decker PA; Sananikone EF; Zhu Y; Tchkonia T; Parney IF; Burma S; Brown D; Rodriguez M; Sarkaria JN; Kirkland JL; Burns TC
Mol Cancer Res; 2022 Jun; 20(6):938-948. PubMed ID: 35191501
[TBL] [Abstract][Full Text] [Related]
8. The Chk1 inhibitor SAR-020106 sensitizes human glioblastoma cells to irradiation, to temozolomide, and to decitabine treatment.
Patties I; Kallendrusch S; Böhme L; Kendzia E; Oppermann H; Gaunitz F; Kortmann RD; Glasow A
J Exp Clin Cancer Res; 2019 Oct; 38(1):420. PubMed ID: 31639020
[TBL] [Abstract][Full Text] [Related]
9. Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP/KDM4A-dependent histone H3K36 demethylation.
Ding G; Xu X; Li D; Chen Y; Wang W; Ping D; Jia S; Cao L
Cell Death Dis; 2020 Oct; 11(10):893. PubMed ID: 33093461
[TBL] [Abstract][Full Text] [Related]
10. Molecular Dosimetry of Temozolomide: Quantification of Critical Lesions, Correlation to Cell Death Responses, and Threshold Doses.
Stratenwerth B; Geisen SM; He Y; Beltzig L; Sturla SJ; Kaina B
Mol Cancer Ther; 2021 Oct; 20(10):1789-1799. PubMed ID: 34253592
[TBL] [Abstract][Full Text] [Related]
11. Fisetin, a Potent Anticancer Flavonol Exhibiting Cytotoxic Activity against Neoplastic Malignant Cells and Cancerous Conditions: A Scoping, Comprehensive Review.
Kubina R; Krzykawski K; Kabała-Dzik A; Wojtyczka RD; Chodurek E; Dziedzic A
Nutrients; 2022 Jun; 14(13):. PubMed ID: 35807785
[TBL] [Abstract][Full Text] [Related]
12. Dietary flavonoid fisetin targets caspase-3-deficient human breast cancer MCF-7 cells by induction of caspase-7-associated apoptosis and inhibition of autophagy.
Yang PM; Tseng HH; Peng CW; Chen WS; Chiu SJ
Int J Oncol; 2012 Feb; 40(2):469-78. PubMed ID: 21922137
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic Potential and Molecular Mechanisms of the Multitargeted Flavonoid Fisetin.
Rauf A; Abu-Izneid T; Imran M; Hemeg HA; Bashir K; Aljohani ASM; Aljohani MSM; Alhumaydhi FA; Khan IN; Bin Emran T; Gondal TA; Nath N; Ahmad I; Thiruvengadam M
Curr Top Med Chem; 2023; 23(21):2075-2096. PubMed ID: 37431899
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin.
Beltzig L; Frumkina A; Schwarzenbach C; Kaina B
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371895
[TBL] [Abstract][Full Text] [Related]
15. Fisetin Deters Cell Proliferation, Induces Apoptosis, Alleviates Oxidative Stress and Inflammation in Human Cancer Cells, HeLa.
Afroze N; Pramodh S; Shafarin J; Bajbouj K; Hamad M; Sundaram MK; Haque S; Hussain A
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163629
[TBL] [Abstract][Full Text] [Related]
16. Localization matters: nuclear-trapped Survivin sensitizes glioblastoma cells to temozolomide by elevating cellular senescence and impairing homologous recombination.
Reich TR; Schwarzenbach C; Vilar JB; Unger S; Mühlhäusler F; Nikolova T; Poplawski A; Baymaz HI; Beli P; Christmann M; Tomicic MT
Cell Mol Life Sci; 2021 Jul; 78(14):5587-5604. PubMed ID: 34100981
[TBL] [Abstract][Full Text] [Related]
17. Quercetin induces MGMT
Wang W; Yuan X; Mu J; Zou Y; Xu L; Chen J; Zhu X; Li B; Zeng Z; Wu X; Yin Z; Wang Q
Phytomedicine; 2023 Sep; 118():154933. PubMed ID: 37451151
[TBL] [Abstract][Full Text] [Related]
18. Fisetin Induces Apoptosis of HSC3 Human Oral Cancer Cells Through Endoplasmic Reticulum Stress and Dysfunction of Mitochondria-mediated Signaling Pathways.
Shih YL; Hung FM; Lee CH; Yeh MY; Lee MH; Lu HF; Chen YL; Liu JY; Chung JG
In Vivo; 2017; 31(6):1103-1114. PubMed ID: 29102932
[TBL] [Abstract][Full Text] [Related]
19. The flavonoid fisetin as an anticancer agent targeting the growth signaling pathways.
Rengarajan T; Yaacob NS
Eur J Pharmacol; 2016 Oct; 789():8-16. PubMed ID: 27377217
[TBL] [Abstract][Full Text] [Related]
20. Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment with etoposide and temozolomide.
Sato Y; Kurose A; Ogawa A; Ogasawara K; Traganos F; Darzynkiewicz Z; Sawai T
Cancer Biol Ther; 2009 Mar; 8(5):452-7. PubMed ID: 19305157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
